RT
RetinalGenix Technologies Inc.
RTGN · OTC
$3.99 +0.00% (+$0.00)
1M +0.00%
Market Cap $75.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$2.38
40.4% downside
Trenutna cena
$3.99
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RTGN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive EV/EBITDA 116.47x
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 6,487.05%
Asset turnover 0.00x
ROIC 3.00%
Debt
79 /100
Low Int. coverage 89.14x
Net debt/EBITDA 0.04x
Current ratio 0.01x
Stability
19 /100
Unstable EPS volatility 86.03%
Profitable years 0
Beta -3.32x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RTGN
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Jerry Katzman
Employees
0
Headquarters
Apollo Beach